ArticleAmerican journal of translational research2019

DPP-4 inhibitor saxagliptin ameliorates oxygen deprivation/reoxygenation-induced brain endothelial injury.

Xudong Zeng et al.PubMed ↗Full text ↗

No numbers read from the abstract.